Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage
- 26 August 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 11 (9) , 671-678
Abstract
Epidemiological studies indicated a role for polymorphisms in genes of folate and homocysteine (Hcy) metabolism in the etiology of neurodegenerative disease, congenital defects and coronary artery disease (CAD). This study investigated the effect of several polymorphisms [C677 T, A1298C of methylenetetrahydrofolate reductase (MTHFR) and A66G of methionine synthase reductase (MTRR) genes] on Hcy levels and DNA damage in 68 patients who underwent coronary angiography. Plasma Hcy concentrations were higher in patients with multivessel disease with respect to monovessel disease and no-CAD patients (19.42.6 vs 11.61.2 and 13.71.4 mol/l, respectively; P=0.03). 677TT patients had higher Hcy levels than those with 677CC or 677CT genotypes (26.24.3 vs 13.11.4 and 13.01.4 mol/l, respectively; P=0.0006). No significant associations were found between A1298C and A66G polymorphisms and plasma Hcy levels. Among patients with 677CC genotype, 66GG individuals tended to have higher levels of Hcy than 66AA homozygotes (14.51.9 vs 8.90.7 mol/l, P=0.06). Multivessel disease patients showed an increased frequency of DNA damage, measured by the micronucleus (MN) frequency, as compared to monovessel disease and no-CAD subjects (12.51.1 vs 8.50.8 and 8.20.9, respectively; P=0.006). The MN were positively correlated with Hcy levels (r=0.33, P=0.006) and were significantly higher in subjects with the 677TT genotype compared with the 677CC or 677CT genotypes (14.42.0 vs 8.81.2 and 9.50.7, respectively; P=0.006). A1298C and A66G polymorphisms had no effect on MN frequency. However, among 677TT patients, 66GG subjects tended to have higher levels of MN than those 66AG and 66AA (18.23.6 vs 13.84.0 and 10.31.7, respectively; P=NS). Our results indicate that genetic instability may be associated with increased risk for multiple Hcy-related diseases.Keywords
This publication has 41 references indexed in Scilit:
- Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA HypomethylationJournal of Biological Chemistry, 2000
- Homocysteine and atherothrombosis—mechanisms for injuryEuropean Heart Journal, 2000
- The effect of 677C → T and 1298A → C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjectsBritish Journal of Nutrition, 2000
- Local Hypomethylation in Atherosclerosis Found in Rabbit ec-sod GeneArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina BifidaMolecular Genetics and Metabolism, 1999
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- Folate, vitamin B12, homocysteine status and DNA damage in young Australian adultsCarcinogenesis, 1998
- Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Exclusion of Specific Human Chromosomes into Micronuclei by 5-Azacytidine Treatment of Lymphocyte CulturesExperimental Cell Research, 1994